# Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure

> **NCT00223678** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT00223678
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223678, "Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00223678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*